ACM
Aisling Capital Management’s Nuvation Bio NUVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.95M | Hold |
2,541,009
| – | – | 1.38% | 6 |
|
|
2025
Q1 | $4.47M | Hold |
2,541,009
| – | – | 1.55% | 6 |
|
|
2024
Q4 | $6.76M | Hold |
2,541,009
| – | – | 2.4% | 7 |
|
|
2024
Q3 | $5.82M | Hold |
2,541,009
| – | – | 2.23% | 8 |
|
|
2024
Q2 | $7.42M | Hold |
2,541,009
| – | – | 3.21% | 5 |
|
|
2024
Q1 | $9.25M | Hold |
2,541,009
| – | – | 3.13% | 7 |
|
|
2023
Q4 | $3.84M | Hold |
2,541,009
| – | – | 1.14% | 7 |
|
|
2023
Q3 | $3.4M | Hold |
2,541,009
| – | – | 1.4% | 8 |
|
|
2023
Q2 | $4.57M | Hold |
2,541,009
| – | – | 2.24% | 7 |
|
|
2023
Q1 | $4.22M | Hold |
2,541,009
| – | – | 2.03% | 8 |
|
|
2022
Q4 | $4.88M | Hold |
2,541,009
| – | – | 3.22% | 8 |
|
|
2022
Q3 | $5.69M | Hold |
2,541,009
| – | – | 3.78% | 7 |
|
|
2022
Q2 | $8.23M | Hold |
2,541,009
| – | – | 5.87% | 6 |
|
|
2022
Q1 | $13.4M | Hold |
2,541,009
| – | – | 7.21% | 5 |
|
|
2021
Q4 | $21.6M | Hold |
2,541,009
| – | – | 7.62% | 4 |
|
|
2021
Q3 | $25.3M | Hold |
2,541,009
| – | – | 5.04% | 3 |
|
|
2021
Q2 | $23.7M | Hold |
2,541,009
| – | – | 3.79% | 5 |
|
|
2021
Q1 | $26.6M | Buy |
+2,541,009
| New | +$26.6M | 4.78% | 3 |
|